Double Bond Pharmaceutical International AB Logo

Double Bond Pharmaceutical International AB

Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.

DBP B | SPGR

Overview

Corporate Details

ISIN(s):
SE0007185517 (+1 more)
LEI:
254900U1MWE2YSPREX74
Country:
Sweden
Address:
Virdings Alle 32B, 754 50 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Double Bond Pharmaceutical International AB is a pharmaceutical company specializing in the redevelopment of established drugs to improve their safety and efficacy. The company's strategy centers on applying its proprietary drug delivery technologies to create new formulations of proven medications. Its key platforms include BeloGal®, a biomimetic encapsulation system that enables targeted delivery of active ingredients to specific organs, and an innovative hydrogel for localized treatment. This approach aims to enhance therapeutic effects while minimizing systemic toxicity. The company's pipeline focuses on areas with significant unmet medical needs, such as oncology and infectious diseases. Lead candidates include SI-053 for glioblastoma (brain cancer), SA-033 for liver cancer, and Belopenem for pneumonia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Double Bond Pharmaceutical International AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Double Bond Pharmaceutical International AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Double Bond Pharmaceutical International AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel KVSR
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain ALM
Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea 196170
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg ALVO
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden ALZ
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea 092040
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea 074430
Amphastar Pharmaceuticals Inc. Logo United States of America AMPH
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom N/A
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.